Skip to content
The Policy VaultThe Policy Vault

Nucynta ERCareFirst (Caremark)

Chronic pain

Approval duration

12 months for pain associated with cancer, sickle cell disease, terminal condition, or hospice/palliative care; 6 months for chronic pain